News
India’s cardiovascular monitoring devices market to reach $153m in 2036
India’s cardiovascular monitoring devices market to reach $153m in 2036
The country represents 7% of the Asia-Pacific market in 2025.
Arete Hospitals adopts ‘SkyWalker’ robotic system for knee replacements
The system is designed to work with the NitrX Evolution implant.
Bumrungrad to open $136.8m luxury hospital in Phuket by 2027
Its first phase is scheduled to begin in mid-2027.
South-west Victoria health services to merge from April 2026
The hospital’s urgent care centre will expand onsite and virtual care services.
Sunway Medical Centre Velocity launches ‘Galaxy Watch8’ health package
The package is priced at $392.06 (RM1,600).
Healthcare digital signage to hit $1.1b by 2030
Real-time patient communication fuels digital signage adoption.
Nearly 60% of Hongkongers delay medical care, report finds
Cost and lack of information contribute to hesitancy
SMART launches project researching wearable ultrasound system for elderly care
MIT, Singapore partners project invests millions on groundbreaking health tech innovation
Asia-Pacific strengthens biotech edge amidst scaling constraints
Government investment powers rapid biotech growth.
At-home syphilis test kit market to grow $1.25b
Asia Pacific leads growth in at-home syphilis testing.
Indonesia.md introduces next-gen artificial heart device
The device targets Indonesia’s heart-failure gap with a smaller, lighter design backed by Singapore.
Global dental laboratories market projected to reach $13.09b by 2030
Asia Pacific dental labs expected highest CAGR growth.
New SPECT-CT scanner installed at Wellington Regional Hospital
It replaces an older model and will work alongside a recently installed unit.
Hong Kong’s hospital dental clinics to join OMS service in 2026
The integration covers seven HDS clinics.
IHH Healthcare to expand network in India
The group’s shareholding now stands at 31.17% in Fortis and 62.73% in Malar.
Perennial Holdings launches Healthcare City in Chongqing, China
Its first phase involves a total investment of approximately $212.8m (RMB1.5b).
What lies ahead for the cell and gene therapy market?
Major investors have committed over $3.5b across cumulative deals.
Most Read
1. iX Biopharma secures $52.8m US contract for pain reliever trials 2. DBS’ $72m loan to PLife REIT to finance elder care in Japan 3. Aging population drives demand for durable medical equipment market 4. Hong Kong outlines ‘One plus Three’ model for life and health tech R&D 5. Tam Anh invests $77m in proton therapy systemResource Center
Read Here
Advertise
Sign Up
Events
Event News
He discusses how healthcare systems in Asia Pacific need to evolve beyond simply expanding coverage and towards delivering equitable, sustainable, and high-impact care.
